Sodium FluorideF 18 (University of Texas MD Anderson Cancer Center)
Welcome to the PulseAid listing for the Sodium Fluoride drug offered from University of Texas MD Anderson Cancer Center. This Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | University of Texas MD Anderson Cancer Center |
NON-PROPRIETARY NAME: | SODIUM FLUORIDE F-18 |
SUBSTANCE NAME: | SODIUM FLUORIDE F-18 |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Radioactive Diagnostic Agent [EPC],Radiopharmaceutical Activity [MoA] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-12-16 |
END MARKETING DATE: | 0000-00-00 |
Sodium Fluoride F 18 HUMAN PRESCRIPTION DRUG Details:
Item Description | Sodium Fluoride F 18 from University of Texas MD Anderson Cancer Center |
LABELER NAME: | University of Texas MD Anderson Cancer Center |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 200(mCi/mL) |
START MARKETING DATE: | 2011-12-16 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60215-412_b358cd7e-9064-423d-a396-216730696795 |
PRODUCT NDC: | 60215-412 |
APPLICATION NUMBER: | ANDA203247 |
Other SODIUM FLUORIDE F-18 Pharmaceutical Manufacturers / Labelers: